Search for: "Novelty Inc."
Results 141 - 160
of 764
Sorted by Relevance
|
Sort by Date
19 Jun 2013, 5:15 am
Defendant Omron Oilfield & Marine, Inc. [read post]
9 Aug 2012, 8:19 am
CALLALLO, INC., App. [read post]
5 Apr 2010, 4:59 am
TEKsystems, Inc. v. [read post]
20 May 2020, 10:09 am
McRO, Inc. v. [read post]
5 Jun 2009, 9:11 am
., Inc. v. [read post]
20 Oct 2008, 1:47 am
Linens 'n Things Inc. began a liquidation sale Friday, and Shoe Pavilion Inc. starts one this weekend, according to firms that said they were hired to liquidate the stores. [read post]
23 Jun 2017, 7:49 am
See Altavion, Inc. v. [read post]
23 Jun 2017, 7:49 am
See Altavion, Inc. v. [read post]
23 Jun 2011, 3:48 am
On May 27, 2011, the Canadian International Trade Tribunal (CITT) issued its decision in Danson Decor Inc. v. [read post]
27 Nov 2007, 12:59 pm
ICC Fabricating, Inc., 67 F.3d 1571, 1577 (Fed. [read post]
15 Aug 2014, 2:27 pm
AOL Inc. [read post]
23 Mar 2007, 6:29 am
It certainly brings the tone of copyright discussions down a meaningful peg.The appeal of JCW Investments Inc v Novelty Inc was decided Wednesday by the US Court of Appeals for the 7th Circuit. [read post]
12 Jun 2018, 2:21 pm
Sys., Inc., 134 S. [read post]
30 Sep 2020, 5:47 am
On September 28, 2020, in Biogen Ma Inc. v. [read post]
8 May 2013, 8:32 am
Power Integrations, Inc. v. [read post]
28 Jan 2013, 6:04 am
Citing Phonometrics, Inc. v. [read post]
27 Feb 2014, 10:10 am
The novelty—and, of course, the absurdity—of Aereo’s service makes it one of the more interesting copyright puzzles. [read post]
6 Apr 2012, 2:23 pm
According to Order Nos. 13, 14, 15, and 16, Respondents PHE, Inc., Momentum Management, LLC, Evolved Novelties Inc., Lelo Inc., Leloi AB, and Lelo moved for summary determination of non-infringement as to U.S. [read post]
15 Dec 2014, 4:11 pm
See, e.g., Duro-Last, Inc. v. [read post]
8 Oct 2015, 9:14 pm
In particular, all seven High Court judges found that claims 1-3 of Myriad Genetics’ Australian patent no. 686004, each of which is directed to isolated nucleic acid molecules corresponding with the BRCA mutation associated with increased breast cancer risk, are invalid because they do not define a patent-eligible ‘manner of manufacture’ under Australian law: D'Arcy v Myriad Genetics Inc [2015] HCA 35.In arriving at this ruling, the High Court has reversed the… [read post]
